Cargando…

Low-Cost High-Throughput Genotyping for Diagnosing Familial Hypercholesterolemia

BACKGROUND: Familial hypercholesterolemia (FH) is a common but underdiagnosed genetic disorder characterized by high low-density lipoprotein cholesterol levels and premature cardiovascular disease. Current sequencing methods to diagnose FH are expensive and time-consuming. In this study, we evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Shirin, van Rooij, Jeroen, Verkerk, Annemieke J.M.H., de Vries, Jard, Zuurbier, Linda, Defesche, Joep, Peter, Jorge, Schonck, Willemijn A.M., Sedaghati-Khayat, Bahar, Kees Hovingh, G., Uitterlinden, André G., Stroes, Erik S.G., Reeskamp, Laurens F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581440/ https://www.ncbi.nlm.nih.gov/pubmed/37675602 http://dx.doi.org/10.1161/CIRCGEN.123.004103

Ejemplares similares

Differential DNA methylation in familial hypercholesterolemia
por: Reeskamp, Laurens F., et al.
Publicado: (2020)

Successful Genetic Screening and Creating Awareness of Familial Hypercholesterolemia and Other Heritable Dyslipidemias in the Netherlands
por: Zuurbier, Linda C., et al.
Publicado: (2021)

Angiopoietin-like 3 inhibition and the liver: less is more?
por: Oostveen, Reindert F., et al.
Publicado: (2023)

ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia—Brief Report
por: Reeskamp, Laurens F., et al.
Publicado: (2021)

The iterative lipid impact on inflammation in atherosclerosis
por: Kraaijenhof, Jordan M., et al.
Publicado: (2021)

New Approaches in Detection and Treatment of Familial Hypercholesterolemia
por: Hartgers, Merel L., et al.
Publicado: (2015)

Linkage analysis and whole exome sequencing identify a novel candidate gene in a Dutch multiple sclerosis family
por: Mescheriakova, Julia Y, et al.
Publicado: (2018)

Quality Assessment of the Genetic Test for Familial Hypercholesterolemia in The Netherlands
por: Kindt, Iris, et al.
Publicado: (2013)

Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association
por: Hemphill, Linda, et al.
Publicado: (2020)

Retrospective analysis of cohort database: Phenotypic variability in a large dataset of patients confirmed to have homozygous familial hypercholesterolemia
por: Raal, Frederick J., et al.
Publicado: (2016)

Taking One Step Back in Familial Hypercholesterolemia: STAP1 Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans
por: Loaiza, Natalia, et al.
Publicado: (2020)

Familial Hypercholesterolemia: Present and Future Management
por: Sjouke, B., et al.
Publicado: (2011)

Risk Assessment for Hip and Knee Osteoarthritis Using Polygenic Risk Scores
por: Sedaghati‐Khayat, Bahar, et al.
Publicado: (2022)

Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
por: Langslet, Gisle, et al.
Publicado: (2020)

Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and Europe
por: Harada-Shiba, Mariko, et al.
Publicado: (2018)

Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
por: Ginsberg, Henry N., et al.
Publicado: (2019)

Genotype–phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia
por: Reijman, M.D., et al.
Publicado: (2023)

Reduced penetrance of pathogenic ACMG variants in a deeply phenotyped cohort study and evaluation of ClinVar classification over time
por: van Rooij, Jeroen, et al.
Publicado: (2020)

Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy
por: Kraaijenhof, Jordan M., et al.
Publicado: (2023)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
por: Laufs, Ulrich, et al.
Publicado: (2019)

From evidence to practice: development of web-based Dutch lipid reference values
por: Nurmohamed, N. S., et al.
Publicado: (2021)

Clinical and pathologic phenotype of a large family with heterozygous STUB1 mutation
por: Mol, Merel O., et al.
Publicado: (2020)

Genetic Risk Factors for Atypical Femoral Fractures (AFFs): A Systematic Review
por: Nguyen, Hanh H, et al.
Publicado: (2018)

Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia
por: Rosenson, Robert S., et al.
Publicado: (2023)

A comparison of genotyping arrays
por: Verlouw, Joost A. M., et al.
Publicado: (2021)

Inflammatory Effects of Triglycerides: Relevant or Redundant?
por: Kraaijenhof, Jordan M., et al.
Publicado: (2023)

Genetic variations of cholesteryl ester transfer protein and diet interactions in relation to lipid profiles and coronary heart disease: a systematic review
por: Mirmiran, Parvin, et al.
Publicado: (2017)

Adrenal Function in Females with Low Plasma HDL-C Due to Mutations in ABCA1 and LCAT
por: Bochem, Andrea E., et al.
Publicado: (2014)

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
por: Ballantyne, Christie M, et al.
Publicado: (2019)

Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study
por: Nurmohamed, Nick S., et al.
Publicado: (2022)

Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries
por: Rosenson, Robert S., et al.
Publicado: (2017)

The Genetics of Atypical Femur Fractures—a Systematic Review
por: Zhou, Wei, et al.
Publicado: (2021)

Severe Dyslipidemia Mimicking Familial Hypercholesterolemia Induced by High-Fat, Low-Carbohydrate Diets: A Critical Review
por: Houttu, Veera, et al.
Publicado: (2023)

Biomarker Expression in Multifocal Vulvar High-Grade Squamous Intraepithelial Lesions
por: Thuijs, Nikki B., et al.
Publicado: (2021)

The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives
por: Cupido, Arjen J., et al.
Publicado: (2021)

Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene
por: Heidemann, Britt E., et al.
Publicado: (2022)

Functional annotation of the human retinal pigment epithelium transcriptome
por: Booij, Judith C, et al.
Publicado: (2009)

How Genetic Variants in Children with Familial Hypercholesterolemia Not Only Guide Detection, but Also Treatment
por: van den Bosch, Sibbeliene E., et al.
Publicado: (2023)

Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study
por: Collard, Didier, et al.
Publicado: (2021)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0a2246rqhj9llmquvtvkvc59dn